Cargando…

COVID-19 update: The race to therapeutic development

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents an unprecedented challenge to global public health. At the time of this review, COVID-19 has been diagnosed in over 40 million cases and associated with 1.1 million deaths worldwide. Current man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Twomey, Julianne D., Luo, Shen, Dean, Alexis Q., Bozza, William P., Nalli, Ancy, Zhang, Baolin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Churchill Livingstone 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584885/ https://www.ncbi.nlm.nih.gov/pubmed/33161277 http://dx.doi.org/10.1016/j.drup.2020.100733

Ejemplares similares

The fight against COVID-19: Striking a balance in the renin–angiotensin system
por: Dean, Alexis Q., et al.
Publicado: (2021)

Targeting cancer with antibody-drug conjugates: Promises and challenges
por: Dean, Alexis Q., et al.
Publicado: (2021)

Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics
por: Twomey, Julianne D., et al.
Publicado: (2021)

Circulating Tumor Cells Develop Resistance to TRAIL-Induced Apoptosis Through Autophagic Removal of Death Receptor 5: Evidence from an In Vitro Model
por: Twomey, Julianne D., et al.
Publicado: (2019)

Exploring the Role of Hypoxia-Inducible Carbonic Anhydrase IX (CAIX) in Circulating Tumor Cells (CTCs) of Breast Cancer
por: Twomey, Julianne D., et al.
Publicado: (2023)

Tubulin couples death receptor 5 to regulate apoptosis
por: Twomey, Julianne D., et al.
Publicado: (2018)

Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases
por: Mamdouhi, Tania, et al.
Publicado: (2019)

Inhibition of RhoA/Rho kinase pathway and smooth muscle contraction by hydrogen sulfide
por: Nalli, Ancy D., et al.
Publicado: (2017)

Urgent needs to accelerate the race for COVID-19 therapeutics
por: Batista, Carolina, et al.
Publicado: (2021)

Therapeutics for COVID-19 and post COVID-19 complications: An update
por: Basu, Debdoot, et al.
Publicado: (2022)

A Recent Achievement in the Discovery and Development of Vaccines and Therapeutic Agents in the Race for COVID-19 Protection and Treatment
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Cytokeratin 8/18 protects breast cancer cell lines from TRAIL-induced apoptosis
por: Bozza, William P., et al.
Publicado: (2018)

Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs
por: Nalli, Ancy D., et al.
Publicado: (2018)

Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac/PLC-ε pathway and modulated by endogenous H(2)S
por: Bala, Vanitha, et al.
Publicado: (2014)

Glycan analysis of therapeutic glycoproteins
por: Zhang, Lei, et al.
Publicado: (2015)

Race to arsenal COVID-19 therapeutics: Current alarming status and future directions
por: Dubey, Ankit Kumar, et al.
Publicado: (2020)

Race, ethnicity, and racism in the nutrition literature: an update for 2020
por: Duggan, Christopher P, et al.
Publicado: (2020)

Regulation of gastric smooth muscle contraction via Ca(2+)-dependent and Ca(2+)-independent actin polymerization
por: Mahavadi, Sunila, et al.
Publicado: (2018)

COVID-19: an update on diagnostic and therapeutic approaches
por: Iyer, Mahalaxmi, et al.
Publicado: (2020)

COVID-19 Outbreak: an Update on Therapeutic Options
por: Panati, Kalpana, et al.
Publicado: (2020)

Just the facts: updates in COVID-19 therapeutics
por: Long, Brit, et al.
Publicado: (2021)

Vitamin D for COVID-19 on Trial: An Update on Prevention and Therapeutic Application
por: Grant, William B., et al.
Publicado: (2021)

The use of lectin microarray for assessing glycosylation of therapeutic proteins
por: Zhang, Lei, et al.
Publicado: (2016)

Dextrose-mediated aggregation of therapeutic monoclonal antibodies in human plasma: Implication of isoelectric precipitation of complement proteins
por: Luo, Shen, et al.
Publicado: (2015)

The race to a COVID-19 vaccine: opportunities and challenges in development and distribution
por: Burgos, Rodrigo M, et al.
Publicado: (2021)

Super-rapid race for saving lives by developing COVID-19 vaccines
por: Uttarilli, Anusha, et al.
Publicado: (2021)

An Update on Current Therapeutic Drugs Treating COVID-19
por: Wu, Renyi, et al.
Publicado: (2020)

An update to “novel therapeutic approaches for treatment of COVID-19”
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2021)

Race, Gender, and the Development of Cross-Race Egalitarianism
por: Gaither, Sarah E., et al.
Publicado: (2020)

On Race and the Environment in the COVID-19 Pandemic
por: Perez, Rafael, et al.
Publicado: (2020)

Race, COVID-19 and deaths of despair
por: Arena, Patrick J., et al.
Publicado: (2020)

The association of race and COVID-19 mortality
por: Golestaneh, Ladan, et al.
Publicado: (2020)

Race for a COVID-19 vaccine
Publicado: (2020)

COVID 19: Surgery & the question of race
por: Collier, Karole T., et al.
Publicado: (2020)

COVID-19: The race for a vaccine
por: Lockey, Emily
Publicado: (2020)

COVD-23. PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
por: Schaff, Lauren, et al.
Publicado: (2020)

COVID-19 in pregnancy by race and ethnicity: Implications for development of a vaccination strategy
por: Pressman, Alice, et al.
Publicado: (2021)

An update to monoclonal antibody as therapeutic option against COVID-19
por: Deb, Paroma, et al.
Publicado: (2021)

Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications
por: Ma, Zhangjing, et al.
Publicado: (2022)

Potential therapeutic options for COVID-19: an update on current evidence
por: Niknam, Zahra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_37gmc7uet6jf0i0mjjlrkevm1b